Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pattern recognition receptors and inflammasome: Now and beyond. | Mol Cells | 2025 | 40527410 | PubTator, text mining | PubMed |
| Multi-omics exploration of CAV1+ tumor epithelial subcelltype in oral squamous cell carcinoma and its impact on the immune microenvironment. | Discov Oncol | 2025 | 40471478 | PubTator, text mining | PubMed |
| The Neurophysiological Effects of Cervical Transcutaneous Spinal Cord Stimulation With and Without a High Frequency Carrier in Able-Bodied Adults. | Artif Organs | 2025 | 40457929 | PubTator, text mining | PubMed |
| Mucosal Immunity: Lessons from the Lower Respiratory and Small Intestinal Epithelia. | Biomedicines | 2025 | 40426880 | PubTator, text mining | PubMed |
| De novo design mini-binder proteins targeting the glycoproteins D to inhibit PRV replication in PK15 cells. | Int J Biol Macromol | 2025 | 40412691 | PubTator, text mining | PubMed |
| Exploring the Role of Pattern Recognition Receptors as Immunostimulatory Molecules. | Immun Inflamm Dis | 2025 | 40396589 | PubTator, text mining | PubMed |
| The Significance of Nectin Family Proteins in Various Cancerogenous Processes. | Int J Mol Sci | 2025 | 40244005 | PubTator, text mining | PubMed |
| In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment. | ACS Biomater Sci Eng | 2025 | 40223683 | PubTator, text mining | PubMed |
| Innate immune signals triggered on organelle membranes. | J Biochem | 2025 | 40197548 | PubTator, text mining | PubMed |
| Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets. | Cytokine Growth Factor Rev | 2025 | 40169306 | PubTator, text mining | PubMed |
| Analysis and comparison of adverse events of colistin administered by different routes based on the FAERS database. | Sci Rep | 2025 | 40140483 | PubTator, text mining | PubMed |
| Herpes simplex virus 1 envelope glycoprotein C shields glycoprotein D to protect virions from entry-blocking antibodies. | J Virol | 2025 | 40135897 | PubTator, text mining | PubMed |
HIV-1 Tat-induced disruption of epithelial junctions and epithelial-mesenchymal transition of oral and genital epithelial cells lead to increased invasiveness of neoplastic cells and the spread of herpes simplex virus and cytomegalovirus. | Front Immunol | 2025 | 40018040 | PubTator, text mining | PubMed |
| Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy. | Viruses | 2025 | 40007004 | PubTator, text mining | PubMed |
| Tracing glass production in urban centers along the Silk Roads in the early Islamic period. | iScience | 2025 | 39981515 | PubTator, text mining | PubMed |
| Decoding the brain-machine interaction for upper limb assistive technologies: advances and challenges. | Front Hum Neurosci | 2025 | 39981127 | PubTator, text mining | PubMed |
| Heterologous Effects of Pertussis and Influenza Vaccines During Pregnancy on Maternal and Infant Innate Immune Responses: A Pilot Study. | Pediatr Infect Dis J | 2025 | 39951361 | PubTator, text mining | PubMed |
| HSV-1 inhibits melanogenesis of PIG1 cells through downregulation of VN1R5/ERK pathway. | Arch Dermatol Res | 2025 | 39912936 | PubTator, text mining | PubMed |
| Editorial: Oncolytic virotherapy, volume II. | Front Mol Biosci | 2025 | 39906418 | PubTator, text mining | PubMed |
| TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV. | Vet Sci | 2025 | 39852900 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=7